SCHEMBL7043583

SCHEMBL7043583

Cc1ccc(C(=O)C(=O)O)s1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.68
ALDH1A1 P00352 6/20 0.52
KMT2A Q03164 4/20 0.52
POLB P06746 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
NPC1 O15118 8/20 0.43
RAB9A P51151 8/20 0.43
MEN1 O00255 3/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
USP2 O75604 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
HPGD P15428 3/20 0.40
TP53 P04637 3/20 0.40
MAPT P10636 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11337533 0.82 DAO (0.61) DAOALDH1A1KMT2APOLBTDP1
SCHEMBL77302 0.81
SCHEMBL29287170 0.79 DAO (0.95) DAOALDH1A1KMT2APOLBTDP1
SCHEMBL6561680 0.79 DAO (0.95) DAOALDH1A1KMT2APOLBTDP1
Hydrochloric Acid SCHEMBL3049773 0.79 DAO (0.95) DAOALDH1A1KMT2APOLBTDP1
SCHEMBL24573203 0.78 DAO (0.62) DAOALDH1A1KMT2APOLBTDP1
Formaldehyde SCHEMBL27454853 0.77 DAO (0.91) DAOALDH1A1KMT2APOLBTDP1
SCHEMBL24168455 0.77 DAO (0.55) DAOALDH1A1KMT2APOLBTDP1
SCHEMBL2511414 0.77 DAO (0.55) DAOALDH1A1KMT2APOLBTDP1
SCHEMBL1340077 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102264734-A Alkaloid aminoester derivatives and medicinal composition thereof 2011-11-30 CN disclosed
US-6613786-B2 Treating urinary incontinence, asthma, irritable bowel syndrome or male erectile dysfunction BRISTOL-MYERS SQUIBB COMPANY 2003-09-02 US disclosed
US-20030144333-A1 Thiophenyl triazol-3-one derivatives as smooth muscle relaxants HEWAWASAM PIYASENA (US) 2003-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144333-A1 Thiophenyl triazol-3-one derivatives as smooth muscle relaxants PDE3A, ADRB2, ADRB3 DAO 3738/4885ALDH1A1 1237/4885KMT2A 981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.